Calico

Calico(CRC)

LONG BEACH, CA
Biotechnology2 H-1B visas (FY2023)

Focus: Aging treatments

Calico is a life sciences company focused on Aging treatments.

OncologyCardiovascularInfectious DiseasesUnknown
Funding Stage
PUBLIC
Open Jobs
1

Pipeline & Clinical Trials

Pain neuroscience education
Cancer Pain
N/A
Clinical Trials (1)
NCT05581784Effectiveness of a Pain Neuroscience Education Program in Adults With Cancer Pain
N/A
AI-Guided Exercise and Pain Neuroscience Education
Fibromyalgia
N/A
Clinical Trials (1)
NCT06672419Effectiveness of AI-Guided Exercise and Pain Neuroscience Education for Fibromyalgia (FIBROIA)
N/A
Endovascular Aneurysm Repair with Physician Modified Endograft
Juxtarenal Abdominal Aortic Aneurysm
N/A
Intervention with Consolidated Cysteine
COVID-19 (SARS-CoV-2 Infection)
N/A
Clinical Trials (1)
NCT07184398Use of a Cysteine-rich Whey Protein Isolate in Post COVID-19 Cognitive Impairment
N/A
iLUX Treatment System
Meibomian Gland Dysfunction
N/A
Clinical Trials (1)
NCT06278584iLux Treatment for Meibomian Gland Dysfunction
N/A
Clinical Trials (1)
NCT05080959A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy
Phase 2
Phase 2
Clinical Trials (1)
NCT04182880Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain
Phase 2
Analgesic Non Narcotic
Hallux Valgus and Bunion
Phase 2
Clinical Trials (1)
NCT05411861Post-Operative Pain and Opioid Reduction Trial After Bunionectomy
Phase 2
Local anesthetic injection of CPL-01
Bunion
Phase 3
Clinical Trials (1)
NCT05831449CPL-01 in the Management of Postoperative Pain After Bunionectomy
Phase 3
local anaesthetic injection
Hernia, Inguinal
Phase 3
Clinical Trials (1)
NCT05813847Herniorrhaphy for Postoperative Pain
Phase 3

Open Jobs (1)

Interview Prep Quick Facts
Portfolio: 9 clinical trials
H-1B (2023): 2 approvals
SEC Filings: 2 available
Open Roles: 1 active job

Financials (FY2025)

Revenue
$2.8B3%
Net Income
$564M
Cash
$372M

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
2
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub